Throughout 2025, Congress introduced several bills related to the pharmacy benefit management (PBM) industry. As with the 118th Congress in 2024 ...

Stacey McKenna, Resident Senior Fellow, Integrated Harm Reduction, R Street Institute In SUPPORT of Senate Bill 421, “Pharmacist; remote verification and counseling in opioid treatment programs.” ...

Six annual spending bills for the current budget year are awaiting action in the Senate this week, including a key ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

UCB Canada Inc. is pleased to announce Health Canada has granted a Notice of Compliance (NOC) for PrBIMZELX® (bimekizumab injection) indicated for the treatment of adult patients with moderate to ...

The primary care physician system is intended to guide patients using telemedicine tools. The fight over the division of ...

Cardiovascular disease is one of the leading causes of death, yet it is also one of the most preventable. It is time to change this.

This program is designed to prepare pharmacists for careers in pharmaceutical education, research, industry and related areas of specialized practice. Pharmaceutical Sciences focuses on cutting-edge ...

OSRX remains licensed and operational in California, continuing uninterrupted access to compounded ophthalmic medications.

Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ophthalmologists. Biosimilars may offer cost-effective alternatives, potentially ...

The School of Management and the School of Pharmacy and Pharmaceutical Sciences jointly offer a five-year program leading to the Master of Business Administration (MBA)/Doctor of Pharmacy (PharmD) ...

This statement highlights what hospitals, clinicians, and patients are experiencing on the ground — and why commercial ...